Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions
Portfolio Pulse from Jelena Martinovic
Cannabis Bioscience International Holdings (OTC:CBIH) has submitted patents for treatments targeting breast and pancreatic cancers. The company plans to accelerate innovation by submitting additional patents monthly and expanding its research team.
July 01, 2024 | 2:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cannabis Bioscience International Holdings (OTC:CBIH) has submitted patents for breast and pancreatic cancer treatments and plans to submit additional patents monthly. The company is expanding its research team to support these efforts.
The submission of patents for breast and pancreatic cancer treatments is a significant step for CBIH, potentially leading to new revenue streams and market opportunities. The company's plan to submit additional patents monthly and expand its research team indicates a strong commitment to innovation and growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100